BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 26968103)

  • 1. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
    Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of polymorphisms in the Wnt/β-catenin pathway genes on hepatocellular carcinoma risk in a Chinese Han population.
    Li QM; Zhang FQ; Li YF; Xian QJ; Zhang YQ; Li P
    Medicine (Baltimore); 2017 Mar; 96(12):e6127. PubMed ID: 28328801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of Notch receptors in postsurgical patients with hepatitis B virus-related hepatocellular carcinoma.
    Yu T; Han C; Zhu G; Liao X; Qin W; Yang C; Liu Z; Su H; Liu X; Yu L; Liu Z; Lu S; Chen Z; Liang Y; Huang J; Qin X; Gui Y; Li J; Peng T
    Cancer Med; 2017 Jul; 6(7):1587-1600. PubMed ID: 28568708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of PINX1 but not TEP1 Polymorphisms with Progression to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B Virus Infection.
    Sriprapun M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Payungporn S; Tangkijvanich P
    Asian Pac J Cancer Prev; 2016; 17(4):2019-25. PubMed ID: 27221889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
    Cheong JY; Shin HD; Cho SW; Kim YJ
    J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single Nucleotide Polymorphisms in STAT3 and STAT4 and Risk of Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
    Chanthra N; Payungporn S; Chuaypen N; Piratanantatavorn K; Pinjaroen N; Poovorawan Y; Tangkijvanich P
    Asian Pac J Cancer Prev; 2015; 16(18):8405-10. PubMed ID: 26745093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients.
    Al-Qahtani AA; Al-Anazi M; Abdo AA; Sanai FM; Al-Hamoudi W; Alswat KA; Al-Ashgar HI; Khalaf N; Viswan N; Al-Ahdal MN
    Exp Mol Pathol; 2013 Dec; 95(3):255-8. PubMed ID: 23994040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
    Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
    Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
    Zhang QX; Li SL; Yao YQ; Li TJ
    Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations.
    Liu W; Wu J; Yang F; Ma L; Ni C; Hou X; Wang L; Xu A; Song J; Deng Y; Xian L; Li Z; Wang S; Chen X; Yin J; Han X; Li C; Zhao J; Cao G
    Clin Cancer Res; 2019 Sep; 25(18):5525-5536. PubMed ID: 31152021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Single Nucleotide Polymorphism rs1053004 in Signal Transducer and Activator of Transcription 3 (STAT3) with Susceptibility to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
    Chanthra N; Payungporn S; Chuaypen N; Pinjaroen N; Poovorawan Y; Tangkijvanich P
    Asian Pac J Cancer Prev; 2015; 16(12):5069-73. PubMed ID: 26163643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of interleukin-12 gene polymorphism with persistence of hepatitis B virus infection and hepatocellular carcinoma].
    Park JS; Cheong JY; Kang JK; Cho JH; Yu S; Shin HD; Park BL; Cho SW
    Korean J Gastroenterol; 2007 Nov; 50(5):313-8. PubMed ID: 18159163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma.
    Lu LC; Shao YY; Lee YH; Hsieh MS; Hsiao CH; Lin HH; Kao HF; Ma YY; Yen FC; Cheng AL; Hsu CH
    Oncology; 2014; 87(3):159-66. PubMed ID: 25012536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia.
    Suarez M I; Uribe D; Jaramillo CM; Osorio G; Perez JC; Lopez R; Hoyos S; Hainaut P; Pineau P; Navas MC
    Ann Hepatol; 2015; 14(1):64-74. PubMed ID: 25536643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
    Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
    J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
    Kawai-Kitahata F; Asahina Y; Tanaka S; Kakinuma S; Murakawa M; Nitta S; Watanabe T; Otani S; Taniguchi M; Goto F; Nagata H; Kaneko S; Tasaka-Fujita M; Nishimura-Sakurai Y; Azuma S; Itsui Y; Nakagawa M; Tanabe M; Takano S; Fukasawa M; Sakamoto M; Maekawa S; Enomoto N; Watanabe M
    J Gastroenterol; 2016 May; 51(5):473-86. PubMed ID: 26553052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGFBR3 polymorphisms and its haplotypes associated with chronic hepatitis B virus infection and age of hepatocellular carcinoma occurrence.
    Kim JH; Yu SJ; Park BL; Cheong HS; Pasaje CF; Bae JS; Lee HS; Shin HD; Kim YJ
    Dig Dis; 2011; 29(3):278-83. PubMed ID: 21829018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.